Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Lifestyle factors and disease-specific differences in subgroups of Swedish Myasthenia Gravis.

Westerberg E, Landtblom AM, Punga AR.

Acta Neurol Scand. 2018 Dec;138(6):557-565. doi: 10.1111/ane.13017. Epub 2018 Oct 4.

PMID:
30155967
2.

Neuroimaging in the Kleine-Levin Syndrome.

Engström M, Latini F, Landtblom AM.

Curr Neurol Neurosci Rep. 2018 Jul 21;18(9):58. doi: 10.1007/s11910-018-0866-y. Review.

3.

Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor?

Berntsson SG, Kristoffersson A, Boström I, Feresiadou A, Burman J, Landtblom AM.

Acta Neurol Scand. 2018 Oct;138(4):327-331. doi: 10.1111/ane.12963. Epub 2018 May 24.

PMID:
29797711
4.

Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients.

Landtblom AR, Bower H, Andersson TM, Dickman PW, Samuelsson J, Björkholm M, Kristinsson SY, Hultcrantz M.

Leukemia. 2018 Oct;32(10):2203-2210. doi: 10.1038/s41375-018-0027-y. Epub 2018 Jan 30.

PMID:
29535425
5.

Cerebellar ataxia and intrathecal baclofen therapy: Focus on patients´ experiences.

Berntsson SG, Landtblom AM, Flensner G.

PLoS One. 2017 Jun 27;12(6):e0180054. doi: 10.1371/journal.pone.0180054. eCollection 2017.

6.

Patterns of antiepileptic drug prescription in Sweden: A register-based approach.

Bolin K, Berggren F, Berling P, Morberg S, Gauffin H, Landtblom AM.

Acta Neurol Scand. 2017 Nov;136(5):521-527. doi: 10.1111/ane.12776. Epub 2017 Jun 5.

PMID:
28585316
7.

Evidence for cognitive resource imbalance in adolescents with narcolepsy.

Witt ST, Drissi NM, Tapper S, Wretman A, Szakács A, Hallböök T, Landtblom AM, Karlsson T, Lundberg P, Engström M.

Brain Imaging Behav. 2018 Apr;12(2):411-424. doi: 10.1007/s11682-017-9706-y.

8.

Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study.

Wesnes K, Myhr KM, Riise T, Cortese M, Pugliatti M, Boström I, Landtblom AM, Wolfson C, Bjørnevik K.

Mult Scler. 2018 Feb;24(2):150-157. doi: 10.1177/1352458517694088. Epub 2017 Feb 1.

PMID:
28273774
9.

Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?

Niemelä V, Landtblom AM, Blennow K, Sundblom J.

PLoS One. 2017 Feb 27;12(2):e0172762. doi: 10.1371/journal.pone.0172762. eCollection 2017.

10.

Extension of diffuse low-grade gliomas beyond radiological borders as shown by the coregistration of histopathological and magnetic resonance imaging data.

Zetterling M, Roodakker KR, Berntsson SG, Edqvist PH, Latini F, Landtblom AM, Pontén F, Alafuzoff I, Larsson EM, Smits A.

J Neurosurg. 2016 Nov;125(5):1155-1166. Epub 2016 Feb 26.

PMID:
26918468
11.

Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.

Bjørnevik K, Riise T, Bostrom I, Casetta I, Cortese M, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM.

Mult Scler. 2017 Jun;23(7):1018-1024. doi: 10.1177/1352458516671028. Epub 2016 Sep 23.

PMID:
27663872
12.

Altered Brain Microstate Dynamics in Adolescents with Narcolepsy.

Drissi NM, Szakács A, Witt ST, Wretman A, Ulander M, Ståhlbrandt H, Darin N, Hallböök T, Landtblom AM, Engström M.

Front Hum Neurosci. 2016 Aug 3;10:369. doi: 10.3389/fnhum.2016.00369. eCollection 2016.

13.

New hypothesis on pontine-frontal eye field connectivity in Kleine-Levin syndrome.

Engström M, Landtblom AM, Karlsson T.

J Sleep Res. 2016 Dec;25(6):716-719. doi: 10.1111/jsr.12428. Epub 2016 May 27.

14.

Being parents with epilepsy: thoughts on its consequences and difficulties affecting their children.

Gauffin H, Flensner G, Landtblom AM.

Neuropsychiatr Dis Treat. 2015 May 27;11:1291-8. doi: 10.2147/NDT.S74222. eCollection 2015.

15.

Does the changing sex ratio of multiple sclerosis give opportunities for intervention?

Boström I, Landtblom AM.

Acta Neurol Scand. 2015;132(199):42-5. doi: 10.1111/ane.12430. Review.

16.

The EnvIMS Study: Design and Methodology of an International Case-Control Study of Environmental Risk Factors in Multiple Sclerosis.

Magalhaes S, Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Myhr KM, Parpinel M, Pekmezovic T, Riise T, Wolfson D, Zhu B, Wolfson C.

Neuroepidemiology. 2015;44(3):173-81. doi: 10.1159/000381779. Epub 2015 May 7.

17.

Brain circuitries involved in sleep disorders.

Landtblom AM, Engström M.

Front Neurol. 2015 Apr 14;6:66. doi: 10.3389/fneur.2015.00066. eCollection 2015. No abstract available.

18.

[Narcolepsy--rare disease that has received increased attention. Pandemrix vaccination caused a higher incidence among children and adolescents].

Hallböök T, Azakacs A, Bialek F, Feltelius N, Landtblom AM, Malmgren K.

Lakartidningen. 2014 Oct 8-14;111(41):1770-3. Review. Swedish. No abstract available.

19.

Evidence of Conjoint Activation of the Anterior Insular and Cingulate Cortices during Effortful Tasks.

Engström M, Karlsson T, Landtblom AM, Craig AD.

Front Hum Neurosci. 2015 Jan 26;8:1071. doi: 10.3389/fnhum.2014.01071. eCollection 2014.

20.

Epilepsy and violence: case series concerning physical trauma in children of persons with epilepsy.

Gauffin H, Landtblom AM.

Neuropsychiatr Dis Treat. 2014 Nov 14;10:2183-9. doi: 10.2147/NDT.S68438. eCollection 2014.

21.

Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.

Ziemssen T, Bajenaru OA, Carrá A, de Klippel N, Correia de Sá J, Edland A, Frederiksen JL, Heinzlef O, Karageorgiou KE, Lander Delgado RH, Landtblom AM, Macías Islas MA, Tubridy N, Gilgun-Sherki Y.

J Neurol. 2015 Jan;262(1):248. doi: 10.1007/s00415-014-7565-7. No abstract available.

22.

Multi-parametric representation of voxel-based quantitative magnetic resonance imaging.

Engström M, Warntjes JB, Tisell A, Landtblom AM, Lundberg P.

PLoS One. 2014 Nov 13;9(11):e111688. doi: 10.1371/journal.pone.0111688. eCollection 2014.

23.

SPECT in the Kleine-Levin Syndrome, a Possible Diagnostic and Prognostic Aid?

Vigren P, Engström M, Landtblom AM.

Front Neurol. 2014 Sep 23;5:178. doi: 10.3389/fneur.2014.00178. eCollection 2014.

24.

Prevalence and cost of epilepsy in Sweden--a register-based approach.

Bolin K, Berggren F, Landtblom AM.

Acta Neurol Scand. 2015 Jan;131(1):37-44. doi: 10.1111/ane.12297. Epub 2014 Sep 7.

PMID:
25195857
25.

Psychosis in patients with narcolepsy as an adverse effect of sodium oxybate.

Sarkanen T, Niemelä V, Landtblom AM, Partinen M.

Front Neurol. 2014 Aug 20;5:136. doi: 10.3389/fneur.2014.00136. eCollection 2014.

26.

Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study.

Wesnes K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Pekmezovic T, Bjørnevik K, Wolfson C, Pugliatti M, Myhr KM.

Mult Scler. 2015 Apr;21(4):388-95. doi: 10.1177/1352458514546785. Epub 2014 Sep 2.

PMID:
25182290
27.

The sleepy teenager - diagnostic challenges.

Landtblom AM, Engström M.

Front Neurol. 2014 Aug 4;5:140. doi: 10.3389/fneur.2014.00140. eCollection 2014. Review.

28.

A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.

Ziemssen T, Bajenaru OA, Carrá A, de Klippel N, de Sá JC, Edland A, Frederiksen JL, Heinzlef O, Karageorgiou KE, Lander Delgado RH, Landtblom AM, Macías Islas MA, Tubridy N, Gilgun-Sherki Y.

J Neurol. 2014 Nov;261(11):2101-11. doi: 10.1007/s00415-014-7446-0. Epub 2014 Aug 14. Erratum in: J Neurol. 2015 Jan;262(1):248.

29.

Regional variation in prevalence and healthcare utilization due to epilepsy in Sweden.

Bolin K, Berggren F, Landtblom AM.

Acta Neurol Scand. 2014 Dec;130(6):354-9. doi: 10.1111/ane.12274. Epub 2014 Jul 18.

PMID:
25040145
30.

Functional magnetic resonance imaging in narcolepsy and the kleine-levin syndrome.

Engström M, Hallböök T, Szakacs A, Karlsson T, Landtblom AM.

Front Neurol. 2014 Jun 25;5:105. doi: 10.3389/fneur.2014.00105. eCollection 2014. Review.

31.

New data identify an increasing sex ratio of multiple sclerosis in Sweden.

Westerlind H, Boström I, Stawiarz L, Landtblom AM, Almqvist C, Hillert J.

Mult Scler. 2014 Oct;20(12):1578-83. doi: 10.1177/1352458514530021. Epub 2014 May 19.

32.

Reduced thalamic and pontine connectivity in kleine-levin syndrome.

Engström M, Karlsson T, Landtblom AM.

Front Neurol. 2014 Apr 2;5:42. doi: 10.3389/fneur.2014.00042. eCollection 2014.

33.

Normal appearing and diffusely abnormal white matter in patients with multiple sclerosis assessed with quantitative MR.

West J, Aalto A, Tisell A, Leinhard OD, Landtblom AM, Smedby Ö, Lundberg P.

PLoS One. 2014 Apr 18;9(4):e95161. doi: 10.1371/journal.pone.0095161. eCollection 2014.

34.

Effects of gadolinium contrast agent administration on automatic brain tissue classification of patients with multiple sclerosis.

Warntjes JB, Tisell A, Landtblom AM, Lundberg P.

AJNR Am J Neuroradiol. 2014 Jul;35(7):1330-6. doi: 10.3174/ajnr.A3890. Epub 2014 Apr 3.

35.

Thalamic activation in the Kleine-Levin syndrome.

Engström M, Karlsson T, Landtblom AM.

Sleep. 2014 Feb 1;37(2):379-86. doi: 10.5665/sleep.3420.

36.

Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study.

Bjørnevik K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Myhr KM, Pekmezovic T, Wesnes K, Wolfson C, Pugliatti M.

Mult Scler. 2014 Jul;20(8):1042-9. doi: 10.1177/1352458513513968. Epub 2014 Jan 10.

PMID:
24414538
37.

Thalamo-striato-cortical determinants to fatigue in multiple sclerosis.

Engström M, Flensner G, Landtblom AM, Ek AC, Karlsson T.

Brain Behav. 2013 Nov;3(6):715-28. doi: 10.1002/brb3.181. Epub 2013 Oct 11.

38.

Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study.

Lossius A, Riise T, Pugliatti M, Bjørnevik K, Casetta I, Drulovic J, Granieri E, Kampman MT, Landtblom AM, Lauer K, Magalhaes S, Myhr KM, Pekmezovic T, Wesnes K, Wolfson C, Holmøy T.

Mult Scler. 2014 May;20(6):669-74. doi: 10.1177/1352458513505693. Epub 2013 Sep 26.

PMID:
24072723
39.

Age-specific sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg).

Boström I, Stawiarz L, Landtblom AM.

Mult Scler. 2014 Apr;20(4):513-4. doi: 10.1177/1352458513498636. Epub 2013 Aug 6. No abstract available.

PMID:
23921135
40.

Impaired language function in generalized epilepsy: inadequate suppression of the default mode network.

Gauffin H, van Ettinger-Veenstra H, Landtblom AM, Ulrici D, McAllister A, Karlsson T, Engström M.

Epilepsy Behav. 2013 Jul;28(1):26-35. doi: 10.1016/j.yebeh.2013.04.001. Epub 2013 May 4.

41.

Brain and effort: brain activation and effort-related working memory in healthy participants and patients with working memory deficits.

Engström M, Landtblom AM, Karlsson T.

Front Hum Neurosci. 2013 Apr 17;7:140. doi: 10.3389/fnhum.2013.00140. eCollection 2013.

42.

Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.

Tisell A, Leinhard OD, Warntjes JB, Aalto A, Smedby Ö, Landtblom AM, Lundberg P.

PLoS One. 2013 Apr 17;8(4):e61817. doi: 10.1371/journal.pone.0061817. Print 2013.

43.

Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study.

Flensner G, Landtblom AM, Söderhamn O, Ek AC.

BMC Public Health. 2013 Mar 15;13:224. doi: 10.1186/1471-2458-13-224.

44.

Low thalamic NAA-concentration corresponds to strong neural activation in working memory in Kleine-Levin syndrome.

Vigren P, Tisell A, Engström M, Karlsson T, Leinhard Dahlqvist O, Lundberg P, Landtblom AM.

PLoS One. 2013;8(2):e56279. doi: 10.1371/journal.pone.0056279. Epub 2013 Feb 25.

45.

A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q).

Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Myhr KM, Parpinel M, Pekmezovic T, Riise T, Zhu B, Wolfson C.

Acta Neurol Scand Suppl. 2012;(195):43-50. doi: 10.1111/ane.12032.

PMID:
23278656
46.

Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.

Tedeholm H, Lycke J, Skoog B, Lisovskaja V, Hillert J, Dahle C, Fagius J, Fredrikson S, Landtblom AM, Malmeström C, Martin C, Piehl F, Runmarker B, Stawiarz L, Vrethem M, Nerman O, Andersen O.

Mult Scler. 2013 May;19(6):765-74. doi: 10.1177/1352458512463764. Epub 2012 Nov 1.

47.

Association between change in normal appearing white matter metabolites and intrathecal inflammation in natalizumab-treated multiple sclerosis.

Mellergård J, Tisell A, Dahlqvist Leinhard O, Blystad I, Landtblom AM, Blennow K, Olsson B, Dahle C, Ernerudh J, Lundberg P, Vrethem M.

PLoS One. 2012;7(9):e44739. doi: 10.1371/journal.pone.0044739. Epub 2012 Sep 17.

48.

Synthetic MRI of the brain in a clinical setting.

Blystad I, Warntjes JB, Smedby O, Landtblom AM, Lundberg P, Larsson EM.

Acta Radiol. 2012 Dec 1;53(10):1158-63. doi: 10.1258/ar.2012.120195. Epub 2012 Sep 27.

49.

Sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg).

Boström I, Stawiarz L, Landtblom AM.

Mult Scler. 2013 Jan;19(1):46-52. doi: 10.1177/1352458512446169. Epub 2012 Jun 18.

PMID:
22711712
50.

Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in Sweden.

Boström I, Riise T, Landtblom AM.

Neuroepidemiology. 2012;38(4):245-9. doi: 10.1159/000338031. Epub 2012 Jun 5.

Supplemental Content

Loading ...
Support Center